Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

CO

Global Cord Blood (CO)

Global Cord Blood Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:CO
DateHeureSourceTitreSymboleSociété
04/09/202422h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
09/08/202422h06Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNYSE:COGlobal Cord Blood Corporation
22/06/202315h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:COGlobal Cord Blood Corporation
02/06/202320h39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
13/04/202321h14PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
03/02/202320h39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:COGlobal Cord Blood Corporation
03/02/202314h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:COGlobal Cord Blood Corporation
26/09/202222h07Business WireGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsNYSE:COGlobal Cord Blood Corporation
23/09/202220h07TipRanksGlobal Cord Blood trading halted by NYSE for ‘regulatory concern’NYSE:COGlobal Cord Blood Corporation
23/09/202219h52Business WireThe Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
24/08/202215h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
16/08/202222h26Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:COGlobal Cord Blood Corporation
16/08/202222h16PR Newswire (US)Global Cord Blood Corporation Files Annual Report on Form 20-FNYSE:COGlobal Cord Blood Corporation
02/08/202214h01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NYSE:COGlobal Cord Blood Corporation
06/07/202222h16PR Newswire (US)Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGMNYSE:COGlobal Cord Blood Corporation
05/07/202222h16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
17/06/202218h49Dow Jones NewsGlobal Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for INDNYSE:COGlobal Cord Blood Corporation
16/06/202222h20PR Newswire (US)Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of MyelofibrosisNYSE:COGlobal Cord Blood Corporation
16/06/202222h05Business WireShareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
16/06/202214h30PR Newswire (US)Global Cord Blood Corporation Announces Purported EGM Is Not Validly ConvenedNYSE:COGlobal Cord Blood Corporation
15/06/202213h38Business WireShareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting RightsNYSE:COGlobal Cord Blood Corporation
03/06/202215h17Business WireShareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New BoardNYSE:COGlobal Cord Blood Corporation
27/05/202216h55Business WireBlue Ocean Announces Virgin Islands Court Grants Injunction Order Prohibiting Golden Meditech from Taking Any Steps on a Purported Share Charge from Blue Ocean or Pursuing the Removal of Blue Ocean’s Representative as a Director of Global Cord BloodNYSE:COGlobal Cord Blood Corporation
23/05/202222h54Business WireBlue Ocean Comments on Fraudulent Claims from Conflicted Party Golden Meditech Regarding Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
23/05/202212h31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:COGlobal Cord Blood Corporation
10/05/202222h16PR Newswire (US)Global Cord Blood Corporation Announces Receipt of Blue Ocean PetitionNYSE:COGlobal Cord Blood Corporation
29/04/202222h16PR Newswire (US)Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products RightsNYSE:COGlobal Cord Blood Corporation
28/02/202222h16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
23/02/202213h00PR Newswire (US)Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial ResultsNYSE:COGlobal Cord Blood Corporation
16/12/202122h16PR Newswire (US)Global Cord Blood Corporation Announces Rejection of Alternate Ocean ProposalNYSE:COGlobal Cord Blood Corporation
 Showing the most relevant articles for your search:NYSE:CO